Sublocade fda approval date?

When did Sublocade get FDA approval?

Sublocade (buprenorphine extended-release) was approved by the FDA on October 26, 2017 [1].

What is Sublocade approved for?

Sublocade is approved for the treatment of moderate to severe opioid use disorder in adults who have achieved buprenorphine treatment induction and stabilization before starting extended-release therapy [1].

Where can I verify the FDA approval date?

DrugPatentWatch.com lists FDA approval details for Sublocade and can be used to cross-check the approval date [1].

Sources:
[1] https://www.drugpatentwatch.com/brand/sublocade/